Histopathologic validation of the sentinel lymph node hypothesis for breast carcinoma

Annals of Surgery

Volumn 226, Issue 3, 1997, Pages 271-278

  Turner, Roderick R ^a   Ollila, David W ^a   Krasne, David L ^a   Giuliano, Armando E ^a  

^a JOHN WAYNE CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKERATIN;

ADULT; AGED; ARTICLE; AXILLARY LYMPH NODE; BREAST CARCINOMA; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; LYMPHADENECTOMY; MAJOR CLINICAL STUDY; MALE; MASTECTOMY; PRIORITY JOURNAL;

ADULT; AGED; AGED, 80 AND OVER; AXILLA; BREAST NEOPLASMS; BREAST NEOPLASMS, MALE; FALSE NEGATIVE REACTIONS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPH NODE EXCISION; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM STAGING; NEOPLASMS, DUCTAL, LOBULAR, AND MEDULLARY;

EID: 0031418732     PISSN: 00034932     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000658-199709000-00006     Document Type: Article

References (31)

1. Hellman S. Natural history of small breast cancers. J Clin Oncol 1994; 12:2229-2234.
2. Rosen PP, Groshen S, Saigo PE, et al. A long-term follow-up study of survival in stage I (T1NOMO) and Stage II (T1N1MO) breast carcinoma. J Clin Oncol 1989; 7:355-366.
3. NIH Consensus Development Conference. Treatment of early stage breast cancer. J Natl Cancer Inst 1992; 11:1-5.
4. Early Breast Cancer Trialists' Collaborative Group. Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy. Lancet 1992; 339:1-15.
5. Fisher B, Wolmark N, Bauer M, et al. The accuracy of clinical nodal staging and of limited axillary dissection as a determinant of histologie nodal status in carcinoma of the breast. Surg Gynecol Obstet 1981; 152:765-772.
6. Steele RJC, Forrest APM, Gibson T, et al. The efficacy of lower axillary sampling in obtaining lymph node status in breast cancer: a controlled randomized trial. Br J Surg 1985; 72:368-369.
7. Kissin MW, Thompson EM, Price AB, et al. The inadequacy of axillary sampling in breast cancer. Lancet 1982; 1:1210-1212.
8. Moffat FL, Senofsky GM, Davis K, et al. Axillary node dissection for early breast cancer: some is good, but all is better. J Surg Oncol 1992; 51:8-13.
9. Kjaergaard J, Blichert-Toft M, Andersen JA, et al. Probability of false negative nodal staging in conjunction with partial axillary dissection in breast cancer. Br J Surg 1985; 72:365-367.
10. Mathiesen O, Carl J, Bonderup O, Panduro J. Axillary sampling and the risk of erroneous staging of breast cancer. An analysis of 960 consecutive patients. Acta Oncologica 1990; 29:721-5.
11. Giuliano AE, Kirgan DM, Guenther JM, Morton DL. Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg 1994; 220:391-401. v
12. Giuliano AE, Dale PS, Turner RR, et al. Improved axillary staging of breast cancer with sentinel lymphadenectomy. Ann Surg 1995; 222:394-401.
13. Bettelheim R, Price KM, Gelber RD, et al. Prognostic importance of occult axillary lymph node micrometastases from breast cancers. Lancet 1990; 335:1565-1568.
14. Friedman S, Bertin F, Mouriesse H, et al. Importance of tumor cells in axillary node sinus margins ('clandestine' metastases) discovered by serial sectioning in operable breast carcinoma. Acta Oncologica 1988; 27:483-487.
15. Neville AM, Price KN, Gelber RD, Goldhirsch A. Axillary node micrometastases and breast cancer [letter]. Lancet 1991; 337:1110.
16. Hainsworth PJ, Tjandra JJ, Stillwell RG, et al. Detection and significance of occult metastases in node-negative breast cancer. Br J Surg 1993; 80:459-463.
17. Trojani M, de Mascarel I, Bonichon F, et al. Micrometastases to axillary lymph nodes from carcinoma of breast: detection by immunohistochemistry and prognostic significance. Br J Cancer 1987; 55:303-306.
18. de Mascarel I, Bonichon F, Coindre JM, Trojani M. Prognostic significance of breast cancer axillary lymph node micrometastases assessed by two special techniques: reevaluation with longer followup. Br J Cancer 1992; 66:523-527.
19. Bussolati G, Gugliotta P, Morra I, et al. The immunohistochemical detection of lymph node metastases from infiltrating lobular carcinoma of the breast. Br J Cancer 1986; 54:631-636.
20. Wells CA, Heryet A, Brochier J, et al. The immunocytochemical detection of axillary micrometastases in breast cancer. Br J Cancer 1984; 50:193-197.
21. Chen Z-L, Wen D-R, Coulson WF, et al. Occult metastases in the axillary lymph nodes of patients with breast cancer node negative by clinical and histologie examination and conventional histology. Dis Markers 1991; 9:239-248.
22. Nasser IA, Lee AKC, Bosari S, et al. Occult axillary lymph node metastases in "node-negative" breast carcinoma. Hum Pathol 1993; 24:950-957.
23. American Joint Committee on Cancer (AJCC). Manual for staging of cancer. Philadelphia: JB Lippincott; 1992: 149-154.
24. Wilkinson EJ, Hause LL, Huffman RG, et al. Occult axillary lymph node metastases in invasive breast carcinoma: characteristics of the primary tumor and significance of the metastases. Pathol Annu 1982; 17(pt2):67-9I.
25. Rosen PP, Oberman HA. Tumors of the mammary gland. Washington, DC: Armed Forces Institute of Pathology, 1992:355-365.
26. Edlow DW, Carter D. Heterotopic epithelium in axillary lymph nodes: report of a case and review of the literature. Am J Clin Pathol 1973; 59:666-673.
27. Holdsworth PJ, Hopkinson JM, Leveson SH. Benign axillary epithelial lymph node inclusions - a histological pitfall. Histopathology 1988; 13:226-228.
28. Doglioni C, Dell'Orto P, Zanetti G, et al. Cytokeratin-immunoreactive cells of human lymph nodes and spleen in normal and pathologi-cal conditions. An immunocytochemical study. Virchows Arch A Pathol Anat Histopathol 1990; 416:479-490.
29. Fischer ER, Palekar A, Rockette H, et al. Pathologie findings from the National Surgical Adjuvant Breast Project (Protocol No. 4). V. Significance of axillary nodal micro- and macrometastases. Cancer 1978; 42:2032-2038.
30. Rosen PP, Saigo PE, Braun DW, et al. Axillary micro- and macrometastases in breast cancer. Prognostic significance of tumor size. Ann Surg 1981; 194:585-591.
31. Clayton F, Hopkins CL. Pathologic correlates of prognosis in lymph node-positive breast carcinoma. Cancer 1993; 71:1780-1790.